The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide ID: ALA5184610
PubChem CID: 137535295
Max Phase: Preclinical
Molecular Formula: C30H31N9O3
Molecular Weight: 565.64
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C
Standard InChI: InChI=1S/C30H31N9O3/c1-4-41-26-14-23-22(13-24(26)36-28(40)10-8-21-6-5-11-38(21)3)30(32-16-31-23)35-20-7-9-25(19(2)12-20)42-29-15-27-37-34-18-39(27)17-33-29/h7-10,12-18,21H,4-6,11H2,1-3H3,(H,36,40)(H,31,32,35)/b10-8+/t21-/m1/s1
Standard InChI Key: RCXKACUHTAVIBD-ZQAUEJBPSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
-1.4374 -0.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7228 -0.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0110 -0.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0110 -1.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7210 -1.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4374 -1.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7017 -0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4166 -0.6168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4184 -1.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7068 -1.8545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7017 0.6208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4163 1.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4165 1.8586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1294 2.2693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8442 1.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8458 1.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1340 0.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1294 3.0945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5589 2.2692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2735 1.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9881 2.2692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7028 1.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7028 1.0314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9881 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2735 1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1597 -0.1882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3160 0.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9803 -0.2745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1521 -0.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8666 -0.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5813 -0.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8666 -1.4408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2960 -0.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0106 -0.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7640 -0.5385 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.3160 0.0744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9036 0.7887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0968 0.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9776 -1.3356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1521 -1.8567 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1521 -2.6819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8666 -3.0945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
14 18 1 0
15 19 1 0
19 20 1 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 1 0
25 24 1 0
20 25 2 0
24 26 2 0
23 27 1 0
27 28 2 0
28 26 1 0
1 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
31 33 2 0
34 33 1 6
35 34 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 34 1 0
35 39 1 0
6 40 1 0
40 41 1 0
41 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 565.64Molecular Weight (Monoisotopic): 565.2550AlogP: 4.90#Rotatable Bonds: 9Polar Surface Area: 131.69Molecular Species: BASEHBA: 11HBD: 2#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.49CX Basic pKa: 8.70CX LogP: 3.17CX LogD: 1.85Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -1.18
References 1. Li D, Tu Y, Jin K, Duan L, Hong Y, Xu J, Chen N, Zhang Z, Zuo H, Gong W, Zhang J, Wang Q, Qian H, Wang X, Ke Y, Xia G.. (2022) Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment., 65 (7.0): [PMID:35319895 ] [10.1021/acs.jmedchem.1c00710 ]